Abemaciclib mesylate (LY2835219) suppliers
Abemaciclib mesylate (LY2835219)
- CAS:
- 1231930-82-7
- MF:
- C28H36F2N8O3S
- MW:
- 602.71
Suppliers by country/region
Company Type
Properties
- storage temp.
- -20°
- solubility
- Soluble in DMSO (up to at least 25 mg/ml) or in Water (up to at least 25 mg/ml).
- form
- solid
- color
- Off-white
- Stability:
- Stable for 1 year from date of purchase as supplied. Solutions in DMSO or distilled water may be stored at -20° for up to 1 month.
- CAS DataBase Reference
- 1231930-82-7
Safety Information
Use
LY2835219 is an orally-bioavailable dual inhibitor of cyclin-dependent kinase 4 (CDK4) and CDK6 (IC50s = 2 and 10 nM, respectively). Through this mechanism, it blocks phosphorylation of retinoblastoma protein, resulting in arrest of cell cycling in the G1 phase. LY2835219 has antitumor action against xenografts when used alone or in combination with other chemotherapeutic compounds.[Cayman Chemical]
130 supplier list of "Abemaciclib mesylate (LY2835219)"
- Product Name:Abemaciclib methanesulfonate
- Products Intro:Purity: 99.44% | Package: 2mg;30USD|5mg;50USD|10mg;72USD | CustNote: REAGENT;FOR LABORATORY USE ONLY
- Company Type: Trader
- Country/Region: UNITED STATES
- Main Products: Compound Libraries,Noval Small Molecucles,Nature Compounds,Inhibitory Antibodies,Life science Kits
- Product Name:Abemaciclib methanesulfonate;abemaciclib mesylate;LY2835219 (methanesulfonate);LY2835219;LY2835219 mesylate
- Products Intro:Package: 1 mL * 10mM (in DMSO);10 mg;100 mg;2 mg;200 mg;25 mg;5 mg;50 mg | CustNote: REAGENT;FOR LABORATORY USE ONLY
- Company Type: Reagent
- Country/Region: UNITED STATES
- Main Products: Compound Libraries,Noval Small Molecucles,Nature Compounds,Inhibitory Antibodies,Life science Kits
You can find Abemaciclib mesylate (LY2835219) suppliers,
manufacturers, and distributors from countries such as China, United States and the United Kingdom here.
Browse to the tetrahydrofuran product information displayed by the supplier,
as well as the supplier's contact and capability information.